Virtus ETF Advisers’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,568	Closed	-$70.2K	–	790
2024 Q4	$70.2K	Buy	9,568 +674	+8%	+$5.32K	0.03%	377
2024 Q3	$66.6K	Buy	8,894 +156	+2%	+$1.35K	0.03%	433
2024 Q2	$77.8K	Buy	8,738 +108	+1%	+$1.04K	0.04%	417
2024 Q1	$87.4K	Sell	8,630 -591	-6%	-$6.02K	0.05%	385
2023 Q4	$92.8K	Buy	9,221 +5,419	+143%	+$49.5K	0.06%	393
2023 Q3	$35.6K	Sell	3,802 -377	-9%	-$5.38K	0.02%	424
2023 Q2	$103K	Buy	4,179 +274	+7%	+$6.88K	0.06%	370
2023 Q1	$90.9K	Sell	3,905 -1,503	-28%	-$38.4K	0.05%	361
2022 Q4	$137K	Buy	5,408 +713	+15%	+$17.5K	0.07%	373
2022 Q3	$91K	Buy	4,695 +36	+0.8%	+$915	0.04%	424
2022 Q2	$119K	Buy	4,659 +1,285	+38%	+$30K	0.04%	388
2022 Q1	$87K	Sell	3,374 -194	-5%	-$5.75K	0.04%	324
2021 Q4	$149K	Sell	3,568 -1,096	-23%	-$42.9K	0.06%	352
2021 Q3	$203K	Sell	4,664 -248	-5%	-$10.7K	0.09%	265
2021 Q2	$232K	Sell	4,912 -4,302	-47%	-$196K	0.1%	239
2021 Q1	$472K	Buy	9,214 +170	+2%	+$9.16K	0.2%	154
2020 Q4	$242K	Buy	9,044 +43	+0.5%	+$1.4K	0.1%	322
2020 Q3	$309K	Sell	9,001 -1,225	-12%	-$52.7K	0.16%	214
2020 Q2	$419K	Buy	+10,226	New	+$343K	0.2%	183